Full Program

Day 1
08 Nov 2016
Day 2
09 Nov 2016
Day 3
10 Nov 2016
Day 4
11 Nov 2016
8:00 am – 10:30 am

Registration | Breakfast |Opening Remarks

10:45 am – 12:30 pm

Plenary Session I: Frontiers of Metagenomic Medicine

12:30 pm – 2:00 pm

Lunch, Exhibits, and Posters

2:00 pm – 3:00 pm

Plenary Session II: Environmental Crosstalk and the Microbiome

3:00 pm – 3:20 pm

Coffee Break / Exhibits

3:20 pm – 4:40 pm

Plenary Session III: Microbiome Science in Other Spaces and Other Places: Beyond the Gut

Evening Industry Symposium: Danone Nutricia Research

Next-generation scientists (NGS): microbiota, diet, human health
6:00 pm – 7:30 pm

Welcome Reception @ Hilton Americas Hotel

8:15 am – 10:30 am

Plenary Session IV: Does the Host Drive the Microbiome?

10:30 am – 11:00 am

Coffee Break / Exhibits

11:00 am – 12:30 pm

Selected Oral Presentations I

Women & Infant Health

(11:00 - 11:10 AM) (228) Short Talk: The Infant Gut Microbiome, Respiratory Infection, and Repeated Wheeze in the First Year of Life: Findings from the Vitamin D Antenatal Asthma Reduction Trial (VDAART) - Joanne Sordillo (USA)  | (11:10 - 11:20 AM) (229) Short Talk: Early Life Colonization of the Nasopharyngeal Microbiome: a Longitudinal Study in The Gambia - Blake Hanson (USA)  | (11:20 - 11:30 AM) (134) Short Talk: Global Characteristics of the Gut Microbiota in Healthy Dutch Children: the KOALA Birth Cohort Study - Huanzi Zhong (People's Republic of China)

GI and Nutrition

(11:30 - 11:40 AM) (268) Short Talk: Whole Metagenomics Sequencing Give New Insights on Relationships Between FODMAPs Intake, Gut Microbiota and Severity of Symptoms in Irritable Bowel Syndrome - Julien Tap (France) | (11:40 - 11:50 AM) (70) Short Talk: Assessing the Relative Contribution of Genetics and Micro-omics for Predicting Pediatric Crohns Disease - Morgan Langille (Canada) | (11:50 - 12:00 PM) (87) Short Talk: Impact of Gut Microbiota in Obese Mexican Children with High Levels of Endothelial Cell Markers - Khemlal Nirmalkar (Mexico)

Microbiome, Cancer and Immunotherapy

(12:00 - 12:10 PM) (236) Short Talk: Histamine H1 and H2 Receptors Play Critical Roles in Physiological Processes and Tumorigenesis of Inflammation Associated Colon Cancer - Zhongcheng Shi (USA) | (12:10 - 12:20 PM) (101) Short Talk: A Dietary Fiber-deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Promotes Pathogen Access - Mahesh Desai (Luxembourg) | (12:20 - 12:30 PM) (92) Short Talk: Microbial Biomarkers of Relapse after Bone Marrow Transplantation - Jonathan Peled (USA)
12:30 pm – 2:00 pm

Lunch, Exhibits, and Posters

Industry Symposium: Introducing LinEnrich, a target-region quantification method designed for metagenomics research.

Introducing LinEnrich™, a target-region quantification method designed for metagenomics research.
2:00 pm – 3:30 pm

Concurrent Sessions I: Does the Host Drive the Microbiome?

Topic I: Women & Infant Health

(2:00 – 2:30 PM) Influence of Milk on Establishment of Healthy Gut Microbiota in Neonates – David Mills, Ph.D. | (2:30 – 3:00 PM) The Relevance of Maternal Microbiome for Infant Health – Maria Carmen Collado, Ph.D.. | (3:00 – 3:30) Earliest Beginnings: Premature Neonates & Establishment of the Microbiome – Phil Tarr, M.D.

Topic II: Microbiome, Cancer and Immunotherapy

(2:00 – 2:30 PM) The Fiber-Microbiota-butyrate Axis in Tumor Suppression – Scott Bultman, Ph.D. | (2:30 – 3:00 PM) Microbes in the Tumor Microenvironment: Potential Biomarkers of Cancer Treatment Outcomes – Christine Pierce Campbell, Ph.D. | (3:00 – 3:30 PM) Genomics of the Cancer Microbiota – Christian Jobin, Ph.D.

Topic III: GI and Nutrition

(2:00 – 2:30 PM) Microbiota, Diet and the Epigenome of IBD - What are the Links? – Marcus Claesson, Ph.D. | (2:30 – 3:00 PM) Functional Analysis of the Human Intestinal Microbiota – Trevor Lawley, Ph.D. | (3:00 – 3:30 PM) Gut Microbiota Metabolite Trimethylamine Noxide from Metabolomics to Translational Medicine – Zeneng Wang, Ph.D.
3:30 pm – 4:00 pm

Coffee Break / Exhibits

4:00 pm – 5:00 pm

Concurrent Sessions II: Investigations and Interventions on Host Microbiome Interactions

Topic I: Integrative Analysis of Host and Microbiome Properties

(4:00 – 4:20 PM) Multi Omic Analysis of the Pregnancy Microbiome – Gregory Buck, Ph.D. | (4:20 – 4:40 PM) Characterizing the Gut Microbial Ecosystem for Diagnosis and Therapy in Inflammatory Bowel Disease – Hera Vlamakis, Ph.D. | (4:40 – 5:00 PM) Longitudinal Multiomics Microbial Profiling in Healthy and Disease Individuals – George Weinstock, Ph.D.

Topic II: Fecal Transplantation Status of Intervention

(4:00 – 4:20 PM) The Fecal Microbiota Transplant National Registry– Gary Wu, M.D. | (4:20 – 4:40 PM) Establishing a Hospital Based Stool Bank and Fecal Microbiota Transplant Service – Sam Costello, M.D. | (4:50 – 5:00 PM) (30) Short Talk: Next Generation Probiotics Targeting Clostridium Difficile Infection Through Precursor-directed Antimicrobial Biosynthesis - Jennifer Spinler (USA)

Topic III: Targeted Interventions in the Emerging Era of Metagenomics and Pharmaceuticals

(4:00 – 4:20 PM) Bacteriophages – Advantages for Patients Today, an Academic / Industry Alliance - Kristin Wannerberger MSc ChemEng, PhD | (4:30 - 4:40 PM) (163 ) Short Talk: Decreased Butyrate Production and Altered Gut Microbiota is associated with Increased Systolic and Diastolic Blood Pressure in Early Pregnancy - Luisa Gomez Arango (Australia) | (4:40 – 4:50 PM) (96 ) Short Talk: The Early Infant Gut Microbiome Varies In Association with a Maternal High-fat Diet - Derrick Chu (USA) | (4:50-5:00PM) (135 ) Short Talk: Using Human Fecal Minibioreactor Array (MBRA) Communities to Model Colonization Resistance and Microbiome/Intestinal Epithelium Homeostasis - Jennifer Auchtung (USA)

Topic IV: Emerging Roles of the Microbiome in Human Disease

(4:00 – 4:20 PM) The Human Gut Microbiota and the Antibiotic Resistance Genes – Baoli Zhu, Ph.D. | (4:20 – 4:40 PM) The Human Microbiome in Autoimmune Diseases – Nan Qin, Ph.D. | (4:40 – 5:00 PM) Rare Members of the Microbiome as Contributors to Dysbiosis – Ufuk Nalbantoglu, Ph.D.
6:30 pm – 10:00 pm

IHMC Congress Dinner – Location TBD

8:00 am-10:30 am

Plenary Session V: Does the Microbiome Drive the Host?

10:30 am – 11:00 am

Coffee Break / Exhibits

11:00 am-12:30 pm

Selected Oral Presentations II

Novel Models

(11:00 - 11:10 AM) (84) Short Talk: Population-level Monitoring of the Human Gut Microbiome: the Flemish Gut Flora Project - Jeroen Raes (Belgium) | (11:10 - 11:20 AM) (176) Short Talk: Intestinal Microbiota of Patients with Inflammatory Bowel Disease Studied by Quantitative Metagenomics Displays Bacterial Signatures in Relationship with their Phenotype - Nicolas Maziers (France) | (11:20 - 11:30 AM) (242) Short Talk: High-throughput Phenotyping of the Microbial Influences on Host Physiology using C. elegans - Buck Samuel (USA)

Human Study Design / Gut Brain Axis

(11:30 - 11:40 AM) (139) Short Talk: Gut Microbiome Variation in Neurocognitive Food Reward Sensitivity - Kristi Hoffman (USA) | (11:40-11:50 AM) (107) Short Talk: MIMOSA: An Integrative Modeling Framework for Linking Ecological and Metabolic Microbiome Variation - Cecilia Noecker (USA) | (11:50 - 12:00 PM) (116) Short Talk: Increase of Popularity of Microbiome-Corrective Foods, as Detected Using Google Trends - Andrei Volgin (USA)

Pharmacology and Microbiome / Circadian Biology

(12:00 - 12:10 PM) (82 ) Short Talk: Impact of Household Pet Ownership on Gut Microbiome in Infants Following Caesarean Delivery - Hein Min Tun (Canada) | (12:10-12:20 PM) (98 ) Short Talk: Non-invasive Transcriptome is Reflective of Tissue-level Transcriptome and Reveals Information Related to Microbiota-host Interaction in a Mouse Model of NSAID Enteropathy - Canaan Whitfield-Cargile (USA) | (12:20 - 12:30 PM) (50 ) Short Talk: Implications of Yeast and Vaginal Microbiota Interactions on Pregnancy Outcomes - Holly Lewis (United Kingdom)
12:30 pm – 2:00 pm

Lunch, Exhibits, and Posters

2:00 pm – 3:30 pm

Concurrent Sessions III

Topic I: Microbiome Analysis: the Future is Now

(2:00 – 2:30 PM) Human Gut Microbes Impact Host Serum Metabolome and Insulin Sensitivity – Bjorn Nielsen, Ph.D. | (2:30 – 3:00 PM) On Perturbations and Fluxes of the Human Gut Microbiome – Peer Bork, Ph.D. | (3:00 – 3:30 PM) Metagenomic Assemblies for Pathogen Discovery – Sarah Highlander, Ph.D.

Topic II: Microbiome Science Around the Globe

(2:00 – 2:30 PM) Global Health: Africa; Vaginal Microbiome and Persistence of HPV Infection in African Women – Clement Adebamowo, B.M., Ch.B., FWACS, FACS | (2:30 – 3:00 PM) Global Health: Asia – Edelwisa Seqube Mercado, Ph.D. | (3:00 – 3:30 PM) Global Health: Africa – Martin Antonio, Ph.D.

Topic III: Designing the Future of Microbiome Science

(2:00 – 2:30 PM) Exploring the Hidden Diversity and Strain Level Structures of Gut and Skin Microbiomes – Adrian Tett, Ph.D. | (2:30 – 3:00 PM) Clinical Future Approaches – Elizabeth Grice, P.h.D. | (3:00 – 3:30 PM) The Role of the Microbiota in Asthma – Brett Finlay, OC, OBC, FRSC, FCAHS
3:30 pm – 3:45 pm

Coffee Break / Exhibits

3:45 pm – 5:30 pm

Closing Session (Moderators: Owen White, Ph.D., Richard Gibbs, Ph.D.)